These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 17033655)
21. Equivalents in biotechnology patents. Auer HE Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574 [No Abstract] [Full Text] [Related]
22. Ordering life: law and the normalization of biotechnology. Jasanoff S Not Polit; 2001; 17(62):34-50. PubMed ID: 15468485 [No Abstract] [Full Text] [Related]
25. EU states back biotech patent reforms. Dickson D; Butler D Nature; 1993 Dec 23-30; 366(6457):713. PubMed ID: 8264788 [No Abstract] [Full Text] [Related]
26. US acts to lengthen term of patents to help biotechnology. Wadman M Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149 [No Abstract] [Full Text] [Related]
27. Genetics. Trends in human gene patent litigation. Holman CM Science; 2008 Oct; 322(5899):198-9. PubMed ID: 18845733 [No Abstract] [Full Text] [Related]
29. Biotechnology patents: strategies for meeting economic and ethical concerns. Gold ER Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560 [No Abstract] [Full Text] [Related]
30. No room for experiment: the Federal Circuit's narrow construction of the experimental use defense. Ludwig SP; Chumney JC Nat Biotechnol; 2003 Apr; 21(4):453. PubMed ID: 12665827 [No Abstract] [Full Text] [Related]
31. Enzo Biochem v. Gen-Probe: complying with the written description requirement under US patent law. Blaug S; Shuster M; Su H Nat Biotechnol; 2003 Jan; 21(1):97-9. PubMed ID: 12511910 [No Abstract] [Full Text] [Related]
32. Shortened life spans of biotech pioneer patents in Japan: a lesson from the DNA chip. Aida T; Konishi A; Hagiwara M; Hashimoto K Nat Biotechnol; 2007 May; 25(5):533-5. PubMed ID: 17483834 [No Abstract] [Full Text] [Related]
33. Procedure for gene patents. Blecher M Nature; 1993 Jan; 361(6409):199. PubMed ID: 8423844 [No Abstract] [Full Text] [Related]
34. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents. Derzko NM; Behringer JW Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101 [No Abstract] [Full Text] [Related]
35. French refuse to implement biotech patent directive. Louët S Nat Biotechnol; 2000 Aug; 18(8):820. PubMed ID: 10932143 [No Abstract] [Full Text] [Related]
36. US Supreme Court applies strict limits to patents. Robertson D Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532 [No Abstract] [Full Text] [Related]
37. Global biotech expansion taking cues from Bayh-Dole. Howard K Nat Biotechnol; 2004 Jul; 22(7):919-20. PubMed ID: 15259190 [No Abstract] [Full Text] [Related]
38. A guide to drug discovery. Protecting your inventions: the patent system. Webber PM Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385 [TBL] [Abstract][Full Text] [Related]